Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 1, 2021
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
[ Thu, Jul 01st 2021
] - WOPRAI
Danielle Brill Initiated (AGIO) at Hold on, Jul 1st, 2021
Danielle Brill of Raymond James, Initiated "Agios Pharmaceuticals, Inc." (AGIO) at Hold on, Jul 1st, 2021.
Danielle has made no other calls on AGIO in the last 4 months.
There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 1 agrees with Danielle's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Held Target at $54 on, Monday, March 1st, 2021
These are the ratings of the 2 analyists that currently disagree with Danielle
- Michael King of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $88 on, Thursday, June 10th, 2021
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $65 on, Friday, April 30th, 2021
